ArticleCurrent pain and headache reports2025
Risk Factors and Consequences of Cutaneous Allodynia among Individuals with Migraine: A Scoping Review.
Article in Current pain and headache reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewCutaneous allodynia is a frequent complaint among individuals with migraine and serves as a critical marker of central sensitization, which plays a pivotal role in migraine pathophysiology. This can exacerbate migraine severity and diminish quality of life. Understanding the risk factors associated with cutaneous allodynia is essential, as it can help identify individuals at higher risk of developing this condition and guide early intervention strategies. Identifying its consequences provides critical insights into disease progression, treatment response, and disability. Hence, this scoping review aimed to determine the risk factors and consequences of cutaneous allodynia in individuals with migraine. RECENT
findingsA total of 47 studies were included from the 2116 retrieved studies. Most of the studies adopted a cross-sectional design (n = 29). Other designs included cohort (n = 8), longitudinal (n = 4), experimental (n = 2), qualitative (exploratory) (n = 2), and observational (n = 1) research designs. Most participants were individuals diagnosed with migraine aged 18–65 (n = 40), and some studies included the pediatric population (n = 5). The study highlighted various risk factors such as psychological, migraine-associated, neurophysiological, biological, socio-demographic, and lifestyle-related factors. The identified consequences were classified as mental health, physical health, neurophysiological, migraine-associated, and treatment-related consequences. The evaluation of risk factors and consequences of cutaneous allodynia among individuals with migraine significantly highlighted the multidimensional risk factors of cutaneous allodynia and its debilitating effects on the lives of the affected individuals. These factors are significant for designing targeted, multifaceted interventions for managing cutaneous allodynia and thus provide an essential step in effective migraine management.
Indexed as
Identifiers
40694183What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.